Vitória Ferreira Leite
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Vitória Ferreira Leite has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Débora Rosana Alves Braga Silva Montagnoli
Graduate Program in Dentistry, School of Dentistry Universidade Federal de Minas Gerais Belo Horizonte Brazil
2 shared publications - Maria Cássia Ferreira de Aguiar
Department of Oral Pathology and Surgery, School of Dentistry Universidade Federal de Minas Gerais Belo Horizonte Brazil
2 shared publications - Mauro Henrique Nogueira Guimarães de Abreu
Department of Community and Preventive Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
2 shared publications - Renata Castro Martins
Department of Community and Preventive Dentistry, School of Dentistry Universidade Federal de Minas Gerais Belo Horizonte Brazil
2 shared publications - Yasmim Silva Godoy
Universidade Federal de Minas Gerais (UFMG), Faculdade de Odontologia. Belo Horizonte (MG), Brasil
2 shared publications - Alex Junio Silva Cruz
Department of Community and Preventive Dentistry, School of Dentistry, Universidade Federal de Minas Gerais, Belo Horizonte 31270-800, MG, Brazil
1 shared publication
Latest Publications
- Open Access
- 6 March 2025
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 71 (2)
Analysis of Salivary Gland Cancer before and during the COVID-19 Pandemic in Brazil
Introduction: The COVID-19 pandemic has harmed health services, including delays in diagnosing and beginning of cancer treatment. Objective: To analyze and compare the number of salivary gland cancer (SGC) case registrations, staging and time to start treatment (TT) from 2019 to 2022 in Brazil. Method: Data on SGC registrations, gender, age group, type of treatment, staging, and TT were collected from the Oncology Panel. A descriptive analysis of the variables was carried out and the Friedman test was used to compare the number of SGC, staging, and TT records of the years analyzed (p < 0.05), using SPSS v.22.0. Results: For the period investigated, SGC records were more prevalent in males from the fifth decade of life onwards; surgery and radiotherapy were the most frequent therapeutic modalities, and stages IV and III were the most prevalent whenever staging was recorded. TT < 30 days was predominant in all periods, followed by TT > 60 days. SGC, staging and TT records showed median variations between pre- and trans-pandemic periods, but without statistically significant differences (p > 0.05). Conclusion: No significant differences were identified in SGC, staging, and TT records in Brazilian states before and during the COVID-19 pandemic. These results suggest that the Brazilian public health system managed to maintain consistent cancer care, even during the COVID-19 pandemic.
- 6 March 2025
- Published by Revista Brasileira De Cancerologia (RBC) in Revista Brasileira de Cancerologia
- Vol. 71 (2)
Open AccessAnalysis of Salivary Gland Cancer before and during the COVID-19 Pandemic in Brazil
Introduction: The COVID-19 pandemic has harmed health services, including delays in diagnosing and beginning of cancer treatment. Objective: To analyze and compare the number of salivary gland cancer (SGC) case registrations, staging and time to start treatment (TT) from 2019 to 2022 in Brazil. Method: Data on SGC registrations, gender, age group, type of treatment, staging, and TT were collected from the Oncology Panel. A descriptive analysis of the variables was carried out and the Friedman test was used to compare the number of SGC, staging, and TT records of the years analyzed (p < 0.05), using SPSS v.22.0. Results: For the period investigated, SGC records were more prevalent in males from the fifth decade of life onwards; surgery and radiotherapy were the most frequent therapeutic modalities, and stages IV and III were the most prevalent whenever staging was recorded. TT < 30 days was predominant in all periods, followed by TT > 60 days. SGC, staging and TT records showed median variations between pre- and trans-pandemic periods, but without statistically significant differences (p > 0.05). Conclusion: No significant differences were identified in SGC, staging, and TT records in Brazilian states before and during the COVID-19 pandemic. These results suggest that the Brazilian public health system managed to maintain consistent cancer care, even during the COVID-19 pandemic.
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 41 (3) , e00121324
Socioeconomic factors impacting treatment delays in oral and oropharyngeal squamous cell carcinoma: a systematic review
This systematic review investigates associations between socioeconomic factors and treatment delay in adults with oral and oropharyngeal squamous cell carcinoma (OOSCC). Observational studies were searched across five databases (PubMed, Scopus, Web of Science, Embase, and Virtual Health Library) and grey literature. No restrictions were imposed about language or year of publication. Risk of bias was analyzed using the Joanna Briggs Institute tool. The primary outcome was defined as the cut-off points of treatment delays, which was addressed by the studies included. The certainty of evidence was assessed following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. In total, 10 retrospective cohort studies were included in the narrative synthesis. Type of insurance plan, sex, older ages, non-white patients, low education level, treatment in public or regional hospital, need for transition care, and living in regional/remote areas were factors associated with treatment delay for OOSCC. However, methodological limitations regarding the adjustment for confounders, the heterogeneity of the definition of delay (different cut-off points), socioeconomic variables, and the lack of eligible articles from different countries resulted in a very low certainty of evidence due to severe issues of bias, inconsistency, and indirectness according to the GRADE guidelines. The association between socioeconomic factors and OOSCC treatment delay is inconclusive by the available data. Given the complexity of the determinants of access to timely OOSCC treatment, further research is recommended in different countries.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Cadernos de Saude Publica
- Vol. 41 (3) , e00121324
Open AccessSocioeconomic factors impacting treatment delays in oral and oropharyngeal squamous cell carcinoma: a systematic review
This systematic review investigates associations between socioeconomic factors and treatment delay in adults with oral and oropharyngeal squamous cell carcinoma (OOSCC). Observational studies were searched across five databases (PubMed, Scopus, Web of Science, Embase, and Virtual Health Library) and grey literature. No restrictions were imposed about language or year of publication. Risk of bias was analyzed using the Joanna Briggs Institute tool. The primary outcome was defined as the cut-off points of treatment delays, which was addressed by the studies included. The certainty of evidence was assessed following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach. In total, 10 retrospective cohort studies were included in the narrative synthesis. Type of insurance plan, sex, older ages, non-white patients, low education level, treatment in public or regional hospital, need for transition care, and living in regional/remote areas were factors associated with treatment delay for OOSCC. However, methodological limitations regarding the adjustment for confounders, the heterogeneity of the definition of delay (different cut-off points), socioeconomic variables, and the lack of eligible articles from different countries resulted in a very low certainty of evidence due to severe issues of bias, inconsistency, and indirectness according to the GRADE guidelines. The association between socioeconomic factors and OOSCC treatment delay is inconclusive by the available data. Given the complexity of the determinants of access to timely OOSCC treatment, further research is recommended in different countries.